European Neuropsychopharmacology
Volume 20, Issue 7 , Pages 459-466, July 2010

The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments

  • Martin Bares

      Affiliations

    • Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic
    • The Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University, Ruska 87, Prague 10, 100 00, Czech Republic
    • Corresponding Author InformationCorresponding author. Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic. Tel.: +420 266003330; fax: +420 266003337.
  • ,
  • Martin Brunovsky

      Affiliations

    • Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic
    • The Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University, Ruska 87, Prague 10, 100 00, Czech Republic
    • The Department of Neurology, Faculty Hospital Na Bulovce, Prague 8, 180 81, Czech Republic
  • ,
  • Tomas Novak

      Affiliations

    • Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic
    • The Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University, Ruska 87, Prague 10, 100 00, Czech Republic
  • ,
  • Miloslav Kopecek

      Affiliations

    • Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic
    • The Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University, Ruska 87, Prague 10, 100 00, Czech Republic
  • ,
  • Pavla Stopkova

      Affiliations

    • Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic
    • The Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University, Ruska 87, Prague 10, 100 00, Czech Republic
  • ,
  • Peter Sos

      Affiliations

    • Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic
    • The Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University, Ruska 87, Prague 10, 100 00, Czech Republic
  • ,
  • Vladimir Krajca

      Affiliations

    • The Department of Neurology, Faculty Hospital Na Bulovce, Prague 8, 180 81, Czech Republic
    • Faculty of Biomedical Engineering, Czech Technical University in Prague, nam. Sitna 3105, Kladno, 272 01, Czech Republic
  • ,
  • Cyril Höschl

      Affiliations

    • Prague Psychiatric Center, Ustavni 91, Prague 8-Bohnice, 181 03, Czech Republic
    • The Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University, Ruska 87, Prague 10, 100 00, Czech Republic

Received 21 October 2009; received in revised form 10 February 2010; accepted 14 March 2010. published online 26 April 2010.

Abstract 

The aim of the study was to examine whether the reduction of theta prefrontal quantitative EEG (QEEG) cordance after one week of bupropion administration is a predictor of response to a 4-week treatment in patients that had failed to respond to previous antidepressant treatments. Method: EEG data of 18 inpatients were monitored at baseline and after one week. QEEG cordance was computed at 3 frontal electrodes (Fp1, Fp2, Fz). Response to treatment was defined as a ≥50% reduction of MADRS score. Results: Nine of the eleven responders and one of the seven non-responders showed decreased prefrontal cordance value after the first week of treatment (p=0.01). Positive and negative predictive values of cordance reduction for the prediction of response to the treatment were 0.9 and 0.75, respectively. Conclusion: Similar to other antidepressants, the reduction of prefrontal QEEG cordance might be helpful in the prediction of the acute outcome of bupropion treatment.

Keywords: Depression, Treatment outcome, Bupropion, QEEG cordance, Prediction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-977X(10)00067-2

doi:10.1016/j.euroneuro.2010.03.007

European Neuropsychopharmacology
Volume 20, Issue 7 , Pages 459-466, July 2010